Axsome Therapeutics, Flexion Therapeutics, and UroGen Pharma gave investors reasons for excitement.
News & Analysis: Axsome Therapeutics
This startup has rapidly developed two potential blockbusters that are close to the finish line, and hardly anybody's noticed yet.
AXSM earnings call for the period ending March 31, 2019.
These two companies are set to announce important business updates this month.
Axsome Therapeutics and PhaseBio Pharmaceuticals are soaring this year, but the best could be yet to come for each of these red-hot biotech stocks.
This tiny biotech may have found the tastiest low-hanging fruit the industry's ever seen.
Can you guess what these high-flying stocks have in common?
Shares have nearly doubled in March following a string of updates, although there was no news on Monday.
Clinical trial readouts expected before the end of March will put shares of these drugmakers on the move.
Sierra Wireless, Innovative Industrial Properties, and Axsome Therapeutics could generate multibagger returns over the long term.